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Abstract
In the 70ies of the last century, ther term “preanalytical phase” was introduced in the literature. This term describes all actions and aspects of the 
“brain to brain circle” of the medical laboratory diagnostic procedure happening before the analytical phase. The author describes his personal expe-
riences in the early seventies and the following history of increasing awareness of this phase as the main cause of “laboratory errors”. This includes 
the definitions of influence and interference factors as well as the first publications in book, internet, CD-Rom and recent App form over the past 
40 years. In addition, a short summary of previous developments as prerequesits of laboratory diagnostic actions is described from the middle age 
matula for urine collection to the blood collection tubes, anticoagulants and centrifuges. The short review gives a personal view on the possible ca-
uses of missing awareness of preanalytical causes of error and future aspects of new techniques in regulation of requests to introduction of quality 
assurance programs for preanalytical factors.
Key words: influence factors; interference factors; preanalytical factors; amylase in urine; haemolytic samples; anticoagulants; blood collection 
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Introduction
The domain of medical laboratories is the perform-
ance of diagnostic analysis. As such, the adequate 
sample, its transport and storage were always part 
of the diagnostic procedure. After statistical quali-
ty assurance of the analytical procedures was in-
troduced in the late sixties and the early seventies 
(1,2), it became apparent that in addition to the an-
alytical errors, additional extraanalytical causes of 
variables impacted on the ability to generate ac-
curate laboratory results (3).
It has been known for several years that variables 
such as the preparation of the patient for sampling 
(diet, prolonged periods of fasting), time and site 
of sampling (early morning versus afternoon, ve-
nous versus capillary sample), choice of anticoagu-
lant (citrate-, EDTA- or heparinised blood), trans-
port and storage (as whole blood, serum or plas-
ma; at room temperature versus cold condition), 
centrifugation time and temperature, were of in-
fluence on laboratory results (4). However, these 
factors were not quantified, since the analytical 
variable was unknown. As recently as in 2002, Bon-
ini et al. (5) quantified the contribution of the ex-
traanalytical variables on total laboratory error.
How we got aware of extraanalytical 
variables
In the year 1970 being a 32 year old collaborator of 
Otto H. Wieland in Munich, my chief created a po-
sition for me as consultant for laboratory medicine, 
who should keep contact with all physicians and 
departments of the 2000 bed Schwabing commu-
nity hospital. After no similar position existed 
around, I asked my boss regarding my duties. He 
thought that better information about new tests 
they wanted and helping in interpreting new as-
say results would be the major function. I started 
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with a daily phone service and monthly visits in all 
departments from paediatrics to surgery, gynae-
cology, dermatology and various departments of 
internal medicine (cardiology, haematology, dia-
betology, nephrology and infectious diseases). To 
my surprise, most cases that kept me busy were 
the results which the clinician felt suspect, despite 
my demonstration (with the help of internal and 
external quality assurance of the analytical proce-
dure) that the analysis was done correctly. Thus, I 
had to solve problems happening between pa-
tients and the laboratory. At that time, most labs 
did not feel responsible for procedures happening 
outside the laboratory. Some historical examples 
may help to clarify the sometimes strange situa-
tions.
Unexpected high urine amylase activity
In the 1960s, before operating a case with acute 
abdominal pain surgeons ordered to measure 
amylase in urine in order to exclude pancreatitis as 
a possible cause of the abdominal pain. After the 
amylase was increased, the operation was post-
poned, until continuous symptoms forced to oper-
ate. The surgeon said “When looking into the pan-
creas, there was no sign of pancreatitis, hence the 
amylase result must be wrong!”. Having no expla-
nation, we asked the nurses to send several 
patient ś urine having no symptoms. Although 
most cases exhibited normal amylase activity, 
some again exhibited increased values. Having 
asked all persons involved in sampling and trans-
port, it turned out that the nurses collecting and 
transferring the samples, sometimes held discus-
sions close to the open vessels containing the 
urine that had to be delivered to laboratory. Dur-
ing this discussions, quite often drops of nurse ś 
spittle came into contact with the patient ś sam-
ples thus contaminating them with amylase from 
the nurse ś saliva!
A few months later, a patient from internal medi-
cine exhibited high amylase which could not be 
explained by the symptoms and clinical findings. 
This man himself knew about the role of urine 
amylase in detecting pancreatitis and added his 
own saliva by spying into the urine sample before 
delivering it to the ward nurse. In this case of a 
“Muenchhausen syndrome”, where the patient 
creates the symptoms himself, preanalytical as-
pects were helpful to diagnose the real cause, af-
ter the patient had mislead physicians in three 
other hospitals. Replacing urine amylase with 
blood amylase collected in closed systems since 
the early seventies, eliminated this cause of error.
Many haemolytic samples from one ward
One day during rainy weather, nearly half of blood 
samples from one ward exhibited haemolytic se-
rum. At this time, we had introduced new one way 
open glass tubes for sampling blood instead of the 
old reusable glass tubes! However, these could not 
be the cause of haemolysis, since samples from 
other wards in the same tubes did not show 
haemolysis. The widespread hospital area caused 
a 1 km walking distance for the persons bringing 
the samples, of which halve the distance travelled 
was outside the houses. It turned out, that raining 
during transport of samples in the open area had 
led to dilution of blood by rain drops, which caused 
haemolysis due to hypoosmolality. These effects 
were seen more often in winter, when in addition 
cooling increased this effect. Using closed systems 
since the early seventies eliminated this cause of 
haemolysis.
After having collected many such cases in the first 
5 years of consulting, we became aware the proce-
dures happening before the tube entered the lab-
oratory, caused errors we could hardly prevent 
without having more influence on the processes 
happening in the phase outside the laboratory 
which later came to be called “preanalytical phase” 
(6). A report about my experiences in this hospital 
to the clinical chemistry society found interest, but 
at this time were not considered as part of the du-
ties of a clinical chemist and was therefore not in-
cluded in the educational program! In my country 
at least, most laboratories were rather separated 
from the clinical wards defending their quality 
with good analytical precision and accuracy data 
not feeling responsible for the extralaboratory 
processes. Despite this negotiation, more and 
more observations were published which brought 
the preanalytical aspects into focus.
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Influence and interference factors
Trying to define possible causes of unexpected re-
sults stimulated discussions on the possible mech-
anisms. Based on observations of Bürgi, Arau, Swit-
zerland, in 1977 we have defined influence factors 
as biological variables changing the concentration 
of the analyte in the analyzed matrix. On the other 
hand, interferences were defined as factors which 
are different from the analyte intended to be 
measured changing the measured result (3,7,8). 
The definition of each factor seemed important 
not only for theoretical reasons. Only interferences 
are method dependent and can in many cases be 
reduced or even eliminated by changes in the ana-
lytical procedure (7). Thus, drug interferences were 
reduced by specific reagents and analytical proce-
dures (9,10), the effect of serum colour changes as 
appearing in haemolytic, turbid and icteric sam-
ples could be reduced by changing reference 
wavelengths or time (kinetic versus fixed time) or 
mechanism of the colorimetric analysis (11,12). The 
effect of influence factors, on the other hand, can 
be reduced only by standardization of the preana-
lytical processes. These were part of old recom-
mendations in preparation of patient (fasting be-
fore sampling, posture before and during sam-
pling) (13).
The term preanalytical phase was built
In 1977, the term preanalytical factors was used by 
Statland and Winkel for variables influencing the 
result before sampling (6). In the 1980s, the terms 
influence and interference factors were included 
into the educational and professional programs 
(14-17). For the first time, Einer and Zawta pub-
lished a book on preanalytical variables in 1987 
(14). The terms influence and interference factors 
became part of terminology of laboratory sciences 
(18) and national as well as international standards 
(for example 19, 20). The National Committee for 
Clinical Laboratory Standards (now Clinical and 
Laboratory Standards Institute, CLSI) introduced 
preanalytical standards in 1981, which were par-
tially followed by respective European Standards 
(European Committee on Clinical Laboratory 
Standards, ECCLS). After the analytical process was 
redefined as examination procedure, the term pre-
analytical procedures was superseded by preex-
amination procedures (20).
By these actions, the term preanalytical phase was 
included in Textbooks (21) and teaching books of 
laboratory medicine (22,23). In 2002, Bonini et al. 
published that preanalytical errors make up more 
than 60% of errors in laboratory medicine (5). Ri-
cos et al. (24,25) helped to define biological varia-
tion for each analyte as a basis for defining prean-
alytical and total laboratory quality indicators. At 
this time, many national quality assurance pro-
grams had been initiated. In seven meetings on 
preanalytical variables, organized as satellites of 
european or international meetings (26-32), the 
various activities and results were exchanged and 
intensively discussed. In addition, WHO published 
the recommendations on sample type and stabili-
ty in 2002 (33), which has appeared in a printed 
version in several languages and editions (34) (7th 
in German 2009, 3rd version in english 2010, App – 
Version in German 2013). This increasing impor-
tance and awareness of preanalytical variables led 
to the first and now second EFLM-BD (European 
Federation of Clinical Chemistry and Laboratory 
Medicine - Becton Dickinson) conference on pre-
analytical phase (35,36).
It is to be hoped that the awareness of the impor-
tance of the preanalytical phase on the quality of 
medical laboratory results leads to a broader im-
plementation of preanalytical aspects into nation-
al and international quality assurance programs, 
which may help to reduce its often underestimat-
ed portion of errors in laboratory results.
Long history before the term 
preanalytical phase appeared
More than 35 years after introduction of the term 
preanalytical phase it seems adequate to mention 
that the data on preanalytical phase would not 
have been attained without a background of more 
than hundred years of history behind it (37). Since 
chemical and microscopic analysis of body fluids 
improved medical diagnosis, the type of sample, 
time of sampling as well as the preparation of pa-
tients has been part of the method description. On 
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the other hand, there have been many inventions 
and technical improvements that contributed to 
the standard we use today. Figure 1 summarizes 
some of the preanalytical techniques and inven-
tions which although existing since more than a 
century, still seem a prerequisite for standardized 
preanalytical procedures.
Personal conclusions
Although the term preanalytical phase seems rath-
er new, the procedures and variables of this phase 
were always inseparable part of the diagnostic 
laboratory process. The introduction of quality as-
surance in the analytical process in the sixties, to-
gether with a continuous separation of the indica-
tion of laboratory tests and the procedure of sam-
pling and transport from the laboratories, has cre-
ated the state of unawareness of the many varia-
bles independent of the analytical process influ-
encing the final laboratory result. Before, all results 
not in line with the patient ś situation and there-
fore not accepted by the clinician were defined as 
laboratory errors. Only the defined quality of the 
analytical phase results made aware that uncon-
sidered variables might be the cause of “unsuita-
ble” results. This also can include the definition of 
the evidence of each test ordered (41) as is recently 
documented in recommendations regarding diag-
nostic pathways (42). The future has to introduce 
quantitative quality programs including all kinds 
of preanalytical variables in the routine estimation 
of trueness of medical laboratory results. This can 
be done based on international and national qual-
ity assurance programs (2,20). These may include 
the refusal of tests ordered either unnecessary or 
preanalytically inappropriate (43).
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Figure 1. History of technical products and procedures involved in preanalytical phase.
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